Core Viewpoint - The company is committed to enhancing its operational capabilities and brand influence across the entire supply chain, focusing on both cultivation and sales [1] Group 1 - The company is actively working to improve its full-chain operational capabilities [1] - The company aims to strengthen its brand influence in the market [1] - The company emphasizes the importance of both growing and selling products effectively [1]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [3][6]. Core Insights - The company is focused on building a high-end blueberry brand through a full-chain approach, which creates high-value barriers and enhances profitability [2][6]. - The company has seen rapid growth in its blueberry business, with significant revenue and profit increases projected for the coming years [6][25]. Summary by Sections Company Overview - The company, established in 1999, initially focused on pesticide formulations and has since expanded into fresh produce, particularly blueberries, and other high-end crops [14][15]. - The company has a concentrated ownership structure, with the founder holding a significant portion of shares, ensuring stable management [19][22]. Financial Performance - In 2024, the company achieved a revenue of 52.9 billion yuan, a year-on-year increase of 28.4%, with a net profit of 5.8 billion yuan, reflecting a substantial growth of 148.1% [25][26]. - The blueberry business has become a key driver of revenue, with its contribution to total revenue rising significantly [28][30]. Global Perspective on Demand and Supply - The demand for blueberries in China is expected to grow rapidly, with per capita consumption still significantly lower than in developed countries [34][36]. - China has become the largest producer of blueberries globally, with a total cultivation area of 143.82 million mu and a production volume of 780,000 tons in 2024 [46][50]. Competitive Advantages - The company has established a comprehensive supply chain from planting to sales, ensuring product freshness and quality [2][4]. - The company is leveraging its technological advancements in planting and processing to enhance yield and product quality, positioning itself favorably in the market [2][6].

Core Insights - Nopson (002215.SZ) reported its Q3 2025 results, revealing that 14 institutional investors hold a total of 148 million shares, representing 14.69% of the company's total equity [1] - The top ten institutional investors collectively own 14.62% of the shares, with a 1.48 percentage point increase compared to the previous quarter [1] Institutional Holdings - The number of institutional investors holding Nopson shares has reached 14, with a total holding of 148 million shares [1] - The top ten institutional investors include notable entities such as Shenzhen Nopson Investment Holdings Co., Ltd. and Hong Kong Central Clearing Limited [1] - The increase in holdings by the top ten institutional investors indicates growing confidence in Nopson, as their collective ownership rose by 1.48 percentage points from the last quarter [1] Public Fund Activity - Two public funds increased their holdings in Nopson, namely Huaxia Industry Prosperity Mixed A and Minsheng Jia Yin Xinxi Mixed A, with an increase rate of 0.92% [2] - One public fund, Yinhua Growth Pioneer Mixed, reported a slight decrease in holdings compared to the previous quarter [2] - Five new public funds disclosed their holdings in Nopson this quarter, including Huaxia Excellent Growth Mixed A and Morgan Stanley Quality Life Selected Stock A [2] Social Security Fund and Insurance Capital - One social security fund, Huaxia Fund Management Co., Ltd. - Social Security Fund 422 Combination, increased its holdings by 0.27% [2] - One insurance capital, Qianhai Life Insurance Co., Ltd. - Dividend Insurance Product, also increased its holdings by 1.3% [2] Foreign Investment Trends - One foreign fund, Hong Kong Central Clearing Limited, reported a slight decrease in holdings compared to the previous quarter [2]

Meeting Overview - Shenzhen Noposion Agrochemical Co., Ltd. will hold its first extraordinary general meeting of shareholders in 2025 on November 19, 2025 [1][5] - The meeting will be conducted in a hybrid format, combining on-site voting and online voting [3][5] Meeting Details - The meeting will take place at the company's conference room located at 113 Shui Reservoir Road, Xixiang, Bao'an District, Shenzhen [5] - The registration date for shareholders to attend the meeting is set for November 13, 2025 [4][6] - The meeting will start at 14:30 on November 19, 2025, with online voting available from 9:15 to 15:00 on the same day [2][10] Attendance and Voting - All shareholders registered with China Securities Depository and Clearing Corporation Limited by the registration date are eligible to attend [4] - Shareholders unable to attend can authorize a proxy to vote on their behalf [4][6] - The voting process will include specific time slots for online voting through the Shenzhen Stock Exchange system [10][12] Agenda Items - The main agenda item for the meeting is the resolution regarding the amendment of the company's articles of association, which requires a two-thirds majority of the voting rights held by attending shareholders for approval [6][11] - The resolutions discussed at the meeting were previously approved in the seventh board meetings held on August 18 and October 28, 2025 [6][11] Registration and Contact Information - Registration for the meeting will occur on November 14, 2025, with specific requirements for both corporate and individual shareholders [7][8] - Contact details for inquiries include the company's address, phone number, and email [10]

Core Viewpoint - The company, Shenzhen Noposion Agricultural Science Co., Ltd., has released its third-quarter report for 2025, ensuring the accuracy and completeness of the information disclosed, and has made decisions regarding financial management and governance structure adjustments [7][8][24]. Financial Data Summary - The third-quarter financial report for 2025 has not been audited [6]. - The company has confirmed that there are no adjustments or restatements required for previous accounting data [3]. - The company reported no non-recurring gains or losses during the period [3]. Shareholder Information - The total number of ordinary shareholders and the status of major shareholders have been disclosed, with no changes reported in the top ten shareholders due to securities lending activities [5]. Board Meeting Decisions - The board meeting held on October 28, 2025, approved the third-quarter report with unanimous consent [7][8]. - The board also approved the use of self-owned funds by a subsidiary for purchasing financial products, with an investment limit set at 100 million RMB [24][25]. - The board approved amendments to the company's articles of association and governance structures, which include 38 sub-proposals that require further shareholder approval [10][35]. Investment Management - The subsidiary, Shenzhen Runkang Ecological Environment Co., Ltd., aims to enhance fund utilization efficiency by investing in low-risk financial products [24][25]. - The investment will be limited to safe and stable financial products, with a rolling usage of funds within the approved limit [25][26]. - The investment decision-making authority is delegated to the management team, ensuring compliance with internal controls and risk management measures [28][30]. Governance Structure Changes - The company has revised its articles of association to reflect changes in registered capital and governance practices, increasing the total number of articles from 197 to 207 [34]. - The revisions include updates to meeting rules and management systems, which will enhance corporate governance [35].

Company and Industry Summary Company Overview - The company is focused on the blueberry market, with significant expansion efforts in Yunnan and plans to enter Southeast Asian markets through new plantations in Laos [2][4][10]. Key Financial Performance - In Q3 2025, the company reported total revenue of 4.086 billion yuan and a net profit of 576 million yuan, both showing growth compared to the previous year [3][4]. - The company effectively reduced its non-recurring net profit losses during the off-season through cost control measures, despite an increase in sales expenses [3][4]. Production and Sales Insights - The company achieved a shipment volume of nearly 1,000 tons from new production areas in October 2025, significantly higher than 300-400 tons in the same month last year [2][5]. - For the 2025 production season, the total expected effective fruit volume is between 50,000 to 55,000 tons, with Q4 expected to contribute about 9,000 tons, representing approximately 50% of the total season output [2][5]. - The average selling price of blueberries exceeds 100,000 yuan per ton, aligning with expectations [2][6]. Strategic Initiatives - The company is focusing on the "Aimeizhuang" beauty brand, increasing advertising efforts, and adjusting sales structures to enhance direct supply ratios [4][8][9]. - Expansion into Laos includes the establishment of blueberry plantations totaling approximately 4,000 acres, aimed at addressing land acquisition challenges in Yunnan and supporting regional market expansion [4][10]. Cost Management - The company's cost structure primarily consists of depreciation, production costs, and post-harvest costs. Future efforts will focus on reducing variable costs, with an expected reduction of 2,000 yuan per ton [4][11]. - The company plans to implement detailed management across four major supply chains in Yunnan to align with its expansion and efficiency goals [4][11]. Brand Performance - The "Aimeizhuang" brand is positioned at a 30% higher price point compared to other varieties, with expectations for increased market share in the current production season [12][9]. - The company has implemented strict quality control measures to ensure the best quality for "Aimeizhuang" products, targeting high-end retail channels [9][12]. Market Dynamics - The company faces competition from both domestic and international blueberry producers, with a notable increase in planting scale in Yunnan [16][17]. - Despite reported price declines in blueberries from Peru and Yunnan, the company maintains confidence in its pricing strategy and product freshness compared to imports [17][16]. Future Growth Opportunities - The company continues to explore new business avenues, including deep processing industries for blueberry products and expansion into Southeast Asian markets [18]. - There is still potential for land acquisition in Yunnan, with plans to add approximately 10,000 acres annually while optimizing product quality through the elimination of inferior varieties [18]. Partnerships and Distribution - The company has established a deep partnership with Sam's Club, aiming to expand its supply across the nation and ensure stable supply through designated farms [19].

Core Insights - Nopson (002215) reported a revenue of 407 million yuan for Q3 2025, representing a year-on-year decline of 17.59% [1] - The company recorded a net loss of 72.5 million yuan in Q3 2025, which is a year-on-year decrease of 12.24% [1] Financial Performance - Q3 2025 revenue: 407 million yuan, down 17.59% year-on-year [1] - Q3 2025 net profit: -72.5 million yuan, down 12.24% year-on-year [1]

深圳诺普信作物科学股份有限公司 授权管理制度 第一条 为提高深圳诺普信作物科学股份有限公司（以下简称"公司"）运行效率， 有效控制公司的投资及财务决算风险，健全公司法人治理结构，确保公司规范化运作， 保护公司、股东的合法权益，根据《中华人民共和国公司法》（以下简称"《公司法》"） 及国家有关法律法规的规定，结合《深圳诺普信作物科学股份有限公司章程》（以下简 称"《公司章程》"）和本公司的实际情况，制定本制度。 第二条 本制度所称"授权管理"是指： （一）公司股东会对董事会的授权； （二）董事会对董事长、总经理的授权； （三）公司在具体经营管理过程中的必要授权。 第三条 授权管理的原则是：在保证股东权益的前提下，提高工作效率，使公司经 营管理走向规范化、科学化、程序化。 第四条 股东会是公司的最高权力机构，股东会依法行使《公司章程》规定的以及 董事会权限以上的职权。股东会就专门事项通过决议对董事会授权。 第五条 董事会有权决定下列收购或出售资产、资产抵押、对外长期投资、贷款、 对外担保及关联交易等事项： （一）审议公司在一年内对外投资、购买、出售重大资产、委托理财不超过公司最 近一期经审计合并会计报表总资产30 ...

深圳诺普信作物科学股份有限公司 累积投票制实施细则 第一条 为进一步完善深圳诺普信作物科学股份有限公司（以下简称"公司"） 法人治理结构，规范公司董事的选举，保证股东充分行使权力，根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《上市公司治理准则》《深圳证券交 易所股票上市规则》及《深圳诺普信作物科学股份有限公司公司章程》（以下简称 "《公司章程》"）的有关规定，特制定本实施细则。 第二条 本实施细则所指累积投票制，是指公司股东会选举两名以上（含两名） 董事时，出席股东会的股东所拥有的投票权等于其所持有的股份总数乘以应选董事 人数之积，出席会议股东可以将其拥有的投票权全部投向一位董事候选人，也可以 将其拥有的投票权分散投向多位董事候选人，按得票多少依次决定董事人选。 第三条 本实施细则所称"董事"包括独立董事和非独立董事。由职工代表担 任的董事由公司职工民主选举产生或更换，不适用于本实施细则的相关规定。 第四条 股东会对董事候选人进行表决前，会议主持人应明确告知与会股东对 候选董事实行累积投票方式，董事会必须置备适合实行累积投票方式的选票。董事 会秘书应对累积投票方式、选票填写方法做出说明和解释。 ...

深圳诺普信作物科学股份有限公司 远期结售汇业务内部控制制度 第一章 总则 （一）公司财务部门是远期结售汇业务的经办部门，负责远期结售汇业务的 资金筹集、业务操作、财务处理及日常联系； （二）各子公司总经理和财务部长负责远期结售汇的配合工作和提出相关建 议； （三）公司内部审计部门负责远期结售汇业务的监督工作； 第一条 为规范深圳诺普信作物科学股份有限公司（以下简称"公司"）外 币远期结售汇业务，有效防范和控制外币汇率风险，加强对远期结售汇业务的管 理，根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管 指引第 1 号——主板上市公司规范运作》等相关法律、法规及规范性文件的规定， 结合公司具体实际，特制定本制度。 第二条 远期结售汇是指公司与银行签订远期结售汇合约，约定将来办理结 售汇的外汇币种、金额、汇率和期限，在到期日按照该远期结售汇合同约定的币 种、金额、汇率办理的结售汇。 第三条 本制度适用于公司及各子公司，但未经公司同意，各子公司不得擅 自操作此业务。 第四条 公司从事远期结售汇业务除应遵守国家相关法律法规及规范性文件 规定外，还应遵守本制度的相关规定。 第二章 职责和审批权限 第五条 ...